Grifols cuts pricing but Picard won’t flex

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Grifols cuts pricing but Picard won’t flex

Spanish healthcare firm Grifols has tightened the pricing on the $3.4bn loan backing its takeover of US firm Talecris by 25bp, while bookrunners on the Eu675m senior debt facility backing the Eu1.5bn buy-out of Picard Surgelés, the French frozen foods company, have ruled out a reverse-flex.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • European securitization issuance database
  • Daily newsletters across markets and asset classes
  • 1 weekly securitization podcast

Related articles

Gift this article